메뉴 건너뛰기




Volumn 170, Issue 1, 2016, Pages 226-231

An emerging role of cGMP in the treatment of schizophrenia: A review

Author keywords

CGMP; Minocycline; N methyl d aspartate receptor; Nitric oxide; Phosphodiesterase inhibitor; Schizophrenia

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; MINOCYCLINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; NEUROLEPTIC AGENT;

EID: 84954289177     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.11.015     Document Type: Review
Times cited : (29)

References (76)
  • 1
    • 38749087581 scopus 로고    scopus 로고
    • Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity
    • Ahuja M., Bishnoi M., Chopra K. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 2008, 244(2-3):111-122.
    • (2008) Toxicology , vol.244 , Issue.2-3 , pp. 111-122
    • Ahuja, M.1    Bishnoi, M.2    Chopra, K.3
  • 3
    • 0003472502 scopus 로고    scopus 로고
    • American Psychiatric Association, Arlington, VA
    • American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, Arlington, VA. fifth ed.
    • (2013) Diagnostic and Statistical Manual of Mental Disorders
  • 4
    • 23944476085 scopus 로고    scopus 로고
    • The many faces of nitric oxide in schizophrenia. A review
    • Bernstein H.G., Bogert B., Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophr. Res. 2005, 78(1):69-86.
    • (2005) Schizophr. Res. , vol.78 , Issue.1 , pp. 69-86
    • Bernstein, H.G.1    Bogert, B.2    Keilhoff, G.3
  • 6
    • 33846887598 scopus 로고    scopus 로고
    • Microglial control of neuronal death and synaptic properties
    • Bessis A., Béchade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007, 55(3):233-238.
    • (2007) Glia , vol.55 , Issue.3 , pp. 233-238
    • Bessis, A.1    Béchade, C.2    Bernard, D.3    Roumier, A.4
  • 7
    • 0024378999 scopus 로고
    • Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
    • Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(22):9030-9033.
    • (1989) Proc. Natl. Acad. Sci. U. S. A. , vol.86 , Issue.22 , pp. 9030-9033
    • Bredt, D.S.1    Snyder, S.H.2
  • 8
    • 84864999825 scopus 로고    scopus 로고
    • Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
    • Chaudhry I.B., Hallak J., Husain N., Minhas F., Stirling J., Richardson P., Dursun S., Dunn G., Deakin B. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J. Psychopharmacol. 2012, 26(9):1185-1193.
    • (2012) J. Psychopharmacol. , vol.26 , Issue.9 , pp. 1185-1193
    • Chaudhry, I.B.1    Hallak, J.2    Husain, N.3    Minhas, F.4    Stirling, J.5    Richardson, P.6    Dursun, S.7    Dunn, G.8    Deakin, B.9
  • 9
    • 0033600913 scopus 로고    scopus 로고
    • PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain
    • Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 1999, 274(39):27467-27473.
    • (1999) J. Biol. Chem. , vol.274 , Issue.39 , pp. 27467-27473
    • Christopherson, K.S.1    Hillier, B.J.2    Lim, W.A.3    Bredt, D.S.4
  • 10
    • 84880552098 scopus 로고    scopus 로고
    • Nitric oxide and symptom reduction in schizophrenia
    • Coyle J.T. Nitric oxide and symptom reduction in schizophrenia. JAMA Psychiatry 2013, 70(7):664-665.
    • (2013) JAMA Psychiatry , vol.70 , Issue.7 , pp. 664-665
    • Coyle, J.T.1
  • 11
    • 84859971485 scopus 로고    scopus 로고
    • Minocycline: therapeutic potential in psychiatry
    • Dean O.M., Data-Franco J., Giorlando F., Berk M. Minocycline: therapeutic potential in psychiatry. CNS Drugs 2012, 26(5):391-401.
    • (2012) CNS Drugs , vol.26 , Issue.5 , pp. 391-401
    • Dean, O.M.1    Data-Franco, J.2    Giorlando, F.3    Berk, M.4
  • 17
    • 0026034352 scopus 로고
    • NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway
    • East S.J., Garthwaite J. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway. Neurosci. Lett. 1991, 123(1):17-19.
    • (1991) Neurosci. Lett. , vol.123 , Issue.1 , pp. 17-19
    • East, S.J.1    Garthwaite, J.2
  • 18
    • 0017046959 scopus 로고
    • Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment
    • Ebstein R.P., Biederman J., Rimon R., Zohar J., Belmaker R.H. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment. Psychopharmacology 1976, 51(1):71-74.
    • (1976) Psychopharmacology , vol.51 , Issue.1 , pp. 71-74
    • Ebstein, R.P.1    Biederman, J.2    Rimon, R.3    Zohar, J.4    Belmaker, R.H.5
  • 19
    • 27744494899 scopus 로고    scopus 로고
    • Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction
    • Francis S.H., Corbin J.D. Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction. Urol. Clin. North Am. 2005, 32(4):419-429.
    • (2005) Urol. Clin. North Am. , vol.32 , Issue.4 , pp. 419-429
    • Francis, S.H.1    Corbin, J.D.2
  • 20
    • 21344459311 scopus 로고    scopus 로고
    • Molecular properties of mammalian proteins that interact with cGMP: proteinkinases, cation channels, phosphodiesterases, and multi-drug anion transporters
    • (2005)
    • Francis S.H., Blount M.A., Zoraghi R., Corbin J.D. Molecular properties of mammalian proteins that interact with cGMP: proteinkinases, cation channels, phosphodiesterases, and multi-drug anion transporters. Front. Biosci. 2005, 10:2097-2117. (2005).
    • (2005) Front. Biosci. , vol.10 , pp. 2097-2117
    • Francis, S.H.1    Blount, M.A.2    Zoraghi, R.3    Corbin, J.D.4
  • 21
    • 77956283047 scopus 로고    scopus 로고
    • CGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action
    • Francis S.H., Busch J.L., Corbin J.D., Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol. Rev. 2010, 62(3):525-563.
    • (2010) Pharmacol. Rev. , vol.62 , Issue.3 , pp. 525-563
    • Francis, S.H.1    Busch, J.L.2    Corbin, J.D.3    Sibley, D.4
  • 22
    • 38749139293 scopus 로고    scopus 로고
    • Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
    • Fujita Y., Ishima T., Kunitachi S., Hagiwara H., Zhang L., Iyo M., Hashimoto K. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline. Prog Neuropsychopharmacol Biol. Psychiatry 2007, 32(2):336-339.
    • (2007) Prog Neuropsychopharmacol Biol. Psychiatry , vol.32 , Issue.2 , pp. 336-339
    • Fujita, Y.1    Ishima, T.2    Kunitachi, S.3    Hagiwara, H.4    Zhang, L.5    Iyo, M.6    Hashimoto, K.7
  • 23
    • 84870927178 scopus 로고    scopus 로고
    • What is behind the non-antibiotic properties of minocycline?
    • Garrido-Mesa N., Zarzuelo A., Gálvez J. What is behind the non-antibiotic properties of minocycline?. Pharmacol. Res. 2013, 67(1):18-30.
    • (2013) Pharmacol. Res. , vol.67 , Issue.1 , pp. 18-30
    • Garrido-Mesa, N.1    Zarzuelo, A.2    Gálvez, J.3
  • 24
    • 0024462440 scopus 로고
    • NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
    • Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 1989, 172(4-5):413-416.
    • (1989) Eur. J. Pharmacol. , vol.172 , Issue.4-5 , pp. 413-416
    • Garthwaite, J.1    Garthwaite, G.2    Palmer, R.M.3    Moncada, S.4
  • 25
    • 0020574890 scopus 로고
    • Low CSF concentrations of cyclic GMP in schizophrenia
    • Gattaz W.F., Cramer H., Beckmann H. Low CSF concentrations of cyclic GMP in schizophrenia. Br. J. Psychiatry 1983, 142:288-291.
    • (1983) Br. J. Psychiatry , vol.142 , pp. 288-291
    • Gattaz, W.F.1    Cramer, H.2    Beckmann, H.3
  • 26
    • 84920609519 scopus 로고    scopus 로고
    • Minocycline as add-on treatment decreases the negative symptoms of schizophrenia; a randomized placebo-controlled clinical trial
    • Ghanizadeh A., Dehbozorgi S., Sigaroodi M.O., Rezaei Z. Minocycline as add-on treatment decreases the negative symptoms of schizophrenia; a randomized placebo-controlled clinical trial. Recent Patents Inflamm. Allergy Drug Discov. 2014, 8(3):211-215.
    • (2014) Recent Patents Inflamm. Allergy Drug Discov. , vol.8 , Issue.3 , pp. 211-215
    • Ghanizadeh, A.1    Dehbozorgi, S.2    Sigaroodi, M.O.3    Rezaei, Z.4
  • 28
    • 35148895860 scopus 로고    scopus 로고
    • PDE inhibitors in psychiatry-future options for dementia, depression and schizophrenia?
    • Halene T.B., Siegel S.J. PDE inhibitors in psychiatry-future options for dementia, depression and schizophrenia?. Drug Discov. Today 2007, 12(19-20):870-878.
    • (2007) Drug Discov. Today , vol.12 , Issue.19-20 , pp. 870-878
    • Halene, T.B.1    Siegel, S.J.2
  • 30
    • 33847276567 scopus 로고    scopus 로고
    • Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys
    • Hashimoto K., Tsukada H., Nishiyama S., Fukumoto D., Kakiuchi T., Iyo M. Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys. Biol. Psychiatry 2007, 61(5):577-581.
    • (2007) Biol. Psychiatry , vol.61 , Issue.5 , pp. 577-581
    • Hashimoto, K.1    Tsukada, H.2    Nishiyama, S.3    Fukumoto, D.4    Kakiuchi, T.5    Iyo, M.6
  • 31
    • 0026779303 scopus 로고
    • Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats
    • Hoffman D.C. Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J. Neural Transm. Gen. Sect. 1992, 89(1-2):1-10.
    • (1992) J. Neural Transm. Gen. Sect. , vol.89 , Issue.1-2 , pp. 1-10
    • Hoffman, D.C.1
  • 32
    • 84883188866 scopus 로고    scopus 로고
    • CGMP-dependent protein kinases (cGK)
    • Hofmann F., Wegener J.W. cGMP-dependent protein kinases (cGK). Methods Mol. Biol. 2013, 1020:17-50.
    • (2013) Methods Mol. Biol. , vol.1020 , pp. 17-50
    • Hofmann, F.1    Wegener, J.W.2
  • 34
    • 0032707717 scopus 로고    scopus 로고
    • Nitric oxide as a signaling molecule in the vascular system: an overview
    • Ignarro L.J., Cirino G., Casini A., Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 1999, 34(6):879-886.
    • (1999) J. Cardiovasc. Pharmacol. , vol.34 , Issue.6 , pp. 879-886
    • Ignarro, L.J.1    Cirino, G.2    Casini, A.3    Napoli, C.4
  • 35
    • 84893957793 scopus 로고    scopus 로고
    • Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice
    • Issy A.C., Pedrazzi J.F., Yoneyama B.H., Del-Bel E.A. Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice. Psychopharmacology 2014, 231(4):663-672.
    • (2014) Psychopharmacology , vol.231 , Issue.4 , pp. 663-672
    • Issy, A.C.1    Pedrazzi, J.F.2    Yoneyama, B.H.3    Del-Bel, E.A.4
  • 37
    • 79953296930 scopus 로고    scopus 로고
    • PDE10A inhibitors: novel therapeutic drugs for schizophrenia
    • Kehler J., Nielsen J. PDE10A inhibitors: novel therapeutic drugs for schizophrenia. Curr. Pharm. Des. 2011, 17(2):137-150.
    • (2011) Curr. Pharm. Des. , vol.17 , Issue.2 , pp. 137-150
    • Kehler, J.1    Nielsen, J.2
  • 38
    • 84895073675 scopus 로고    scopus 로고
    • The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
    • Kennedy J.L., Altar C.A., Taylor D.L., Degtiar I., Hornberger J.C. The social and economic burden of treatment-resistant schizophrenia: a systematic literature review. Int. Clin. Psychopharmacol. 2014, 29(2):63-76.
    • (2014) Int. Clin. Psychopharmacol. , vol.29 , Issue.2 , pp. 63-76
    • Kennedy, J.L.1    Altar, C.A.2    Taylor, D.L.3    Degtiar, I.4    Hornberger, J.C.5
  • 40
    • 7044286205 scopus 로고    scopus 로고
    • Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells
    • Kim S.S., Kong P.J., Kim B.S., Sheen D.H., Nam S.Y., Chun W. Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells. Arch. Pharm. Res. 2004, 27(3):314-318.
    • (2004) Arch. Pharm. Res. , vol.27 , Issue.3 , pp. 314-318
    • Kim, S.S.1    Kong, P.J.2    Kim, B.S.3    Sheen, D.H.4    Nam, S.Y.5    Chun, W.6
  • 41
    • 84961931877 scopus 로고    scopus 로고
    • Comparison of PDE9 and PDE10 inhibitors in preclinical schizophrenia models
    • (Online. Available at
    • Kleiman R.J. Comparison of PDE9 and PDE10 inhibitors in preclinical schizophrenia models. Presented at the New York Academy of Sciences, New York, NY 2010, (Online. Available at http://www.nyas.org/Publications/Media/VideoDetail.aspx?cid=2cce36ba-5fd6-4de1-b84e-8b018624bf17).
    • (2010) Presented at the New York Academy of Sciences, New York, NY
    • Kleiman, R.J.1
  • 44
    • 34249804458 scopus 로고    scopus 로고
    • Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia
    • Levkovitz Y., Levi U., Braw Y., Cohen H. Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia. Brain Res. 2007, 1154:154-162.
    • (2007) Brain Res. , vol.1154 , pp. 154-162
    • Levkovitz, Y.1    Levi, U.2    Braw, Y.3    Cohen, H.4
  • 47
    • 57049135076 scopus 로고    scopus 로고
    • In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats
    • Marte A., Pepicelli O., Cavallero A., Raiteri M., Fedele E. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. J. Neurosci. Res. 2008, 86(15):3338-3347.
    • (2008) J. Neurosci. Res. , vol.86 , Issue.15 , pp. 3338-3347
    • Marte, A.1    Pepicelli, O.2    Cavallero, A.3    Raiteri, M.4    Fedele, E.5
  • 49
    • 12344326514 scopus 로고    scopus 로고
    • Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
    • Miyamoto S., Duncan G.E., Marx C.E., Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 2005, 10:79-104.
    • (2005) Mol. Psychiatry , vol.10 , pp. 79-104
    • Miyamoto, S.1    Duncan, G.E.2    Marx, C.E.3    Lieberman, J.A.4
  • 50
    • 84908619928 scopus 로고    scopus 로고
    • Microglial intracellular Ca(2+) signaling as a target of antipsychotic actions for the treatment of schizophrenia
    • Mizoguchi Y., Kato T.A., Horikawa H., Monji A. Microglial intracellular Ca(2+) signaling as a target of antipsychotic actions for the treatment of schizophrenia. Front. Cell. Neurosci. 2014, 8:370.
    • (2014) Front. Cell. Neurosci. , vol.8 , pp. 370
    • Mizoguchi, Y.1    Kato, T.A.2    Horikawa, H.3    Monji, A.4
  • 51
    • 0032575715 scopus 로고    scopus 로고
    • Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
    • Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281(5381):1349-1352.
    • (1998) Science , vol.281 , Issue.5381 , pp. 1349-1352
    • Moghaddam, B.1    Adams, B.W.2
  • 53
    • 33847068206 scopus 로고    scopus 로고
    • Overview of PDEs and their regulation
    • Omori K., Kotera J. Overview of PDEs and their regulation. Circ. Res. 2007, 100(3):309-327.
    • (2007) Circ. Res. , vol.100 , Issue.3 , pp. 309-327
    • Omori, K.1    Kotera, J.2
  • 54
    • 84902595080 scopus 로고    scopus 로고
    • Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia
    • Qurashi I., Collins J., Chaudhry I., Husain N. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia. J. Psychopharmacol. 2014, 28(7):707-708.
    • (2014) J. Psychopharmacol. , vol.28 , Issue.7 , pp. 707-708
    • Qurashi, I.1    Collins, J.2    Chaudhry, I.3    Husain, N.4
  • 55
    • 1842790618 scopus 로고    scopus 로고
    • Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at serine 847 by the N-methyl-d-aspartate receptor
    • Rameau G.A., Chiu L.Y., Ziff E.B. Bidirectional regulation of neuronal nitric-oxide synthase phosphorylation at serine 847 by the N-methyl-d-aspartate receptor. J. Biol. Chem. 2004, 279(14):14307-14314.
    • (2004) J. Biol. Chem. , vol.279 , Issue.14 , pp. 14307-14314
    • Rameau, G.A.1    Chiu, L.Y.2    Ziff, E.B.3
  • 57
    • 0032190029 scopus 로고    scopus 로고
    • Functional properties of a naturally occurring isoform of soluble guanylyl cyclase
    • Russwurm M., Behrends S., Harteneck C., Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 1998, 335(Pt 1):125-130.
    • (1998) Biochem. J. , vol.335 , pp. 125-130
    • Russwurm, M.1    Behrends, S.2    Harteneck, C.3    Koesling, D.4
  • 59
    • 0030844332 scopus 로고    scopus 로고
    • Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test
    • Sams-Dodd F. Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test. Behav. Pharmacol. 1997, 8(2-3):196-215.
    • (1997) Behav. Pharmacol. , vol.8 , Issue.2-3 , pp. 196-215
    • Sams-Dodd, F.1
  • 60
    • 0033599714 scopus 로고    scopus 로고
    • Schizophrenia
    • Schultz S.K., Andreasen N.C. Schizophrenia. Lancet 1999, 353(9162):1425-1430.
    • (1999) Lancet , vol.353 , Issue.9162 , pp. 1425-1430
    • Schultz, S.K.1    Andreasen, N.C.2
  • 61
    • 38849147799 scopus 로고    scopus 로고
    • Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site
    • Shim S.S., Hammonds M.D., Kee B.S. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 258(1):16-27.
    • (2007) Eur. Arch. Psychiatry Clin. Neurosci. , vol.258 , Issue.1 , pp. 16-27
    • Shim, S.S.1    Hammonds, M.D.2    Kee, B.S.3
  • 62
    • 55949132109 scopus 로고    scopus 로고
    • The role of phosphodiesterases in schizophrenia: therapeutic implications
    • Siuciak J.A. The role of phosphodiesterases in schizophrenia: therapeutic implications. CNS Drugs 2008, 22(12):983-993.
    • (2008) CNS Drugs , vol.22 , Issue.12 , pp. 983-993
    • Siuciak, J.A.1
  • 63
    • 0030057542 scopus 로고    scopus 로고
    • The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis
    • Steinpreis R.E. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav. Brain Res. 1996, 74(1-2):45-55.
    • (1996) Behav. Brain Res. , vol.74 , Issue.1-2 , pp. 45-55
    • Steinpreis, R.E.1
  • 64
    • 5844284193 scopus 로고    scopus 로고
    • Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide
    • Stone J.R., Marletta M.A. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 1996, 35(4):1093-1099.
    • (1996) Biochemistry , vol.35 , Issue.4 , pp. 1093-1099
    • Stone, J.R.1    Marletta, M.A.2
  • 65
    • 79951678468 scopus 로고    scopus 로고
    • Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: roles of Bcl-2 and thioredoxin
    • Tang C.M., Hwang C.S., Chen S.D., Yang D.I. Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: roles of Bcl-2 and thioredoxin. Free Radic. Biol. Med. 2011, 50(6):710-721.
    • (2011) Free Radic. Biol. Med. , vol.50 , Issue.6 , pp. 710-721
    • Tang, C.M.1    Hwang, C.S.2    Chen, S.D.3    Yang, D.I.4
  • 66
    • 1442326012 scopus 로고    scopus 로고
    • Minocycline: neuroprotective mechanisms in Parkinson's disease
    • Thomas M., Le W.D. Minocycline: neuroprotective mechanisms in Parkinson's disease. Curr. Pharm. Des. 2004, 10(6):679-686.
    • (2004) Curr. Pharm. Des. , vol.10 , Issue.6 , pp. 679-686
    • Thomas, M.1    Le, W.D.2
  • 67
    • 77949447469 scopus 로고    scopus 로고
    • Strategies to enhance N-methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
    • Tsai G.E., Lin P. Strategies to enhance N-methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr. Pharm. Des. 2010, 16(5):522-537.
    • (2010) Curr. Pharm. Des. , vol.16 , Issue.5 , pp. 522-537
    • Tsai, G.E.1    Lin, P.2
  • 70
    • 27844464469 scopus 로고    scopus 로고
    • Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line
    • Wunder F., Tersteegen A., Rebmann A., Erb C., Fahrig T., Hendrix M. Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line. Mol. Pharmacol. 2005, 68(6):1775-1781.
    • (2005) Mol. Pharmacol. , vol.68 , Issue.6 , pp. 1775-1781
    • Wunder, F.1    Tersteegen, A.2    Rebmann, A.3    Erb, C.4    Fahrig, T.5    Hendrix, M.6
  • 72
    • 84902578330 scopus 로고    scopus 로고
    • Profile of minocycline and its potential in the treatment of schizophrenia
    • Zhang L., Zhao J. Profile of minocycline and its potential in the treatment of schizophrenia. Neuropsychiatr. Dis. Treat. 2014, 10:1103-1111.
    • (2014) Neuropsychiatr. Dis. Treat. , vol.10 , pp. 1103-1111
    • Zhang, L.1    Zhao, J.2
  • 74
    • 34547884686 scopus 로고    scopus 로고
    • Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine
    • Zhang L., Shirayama Y., Iyo M., Hashimoto K. Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine. Neuropsychopharmacology 2007, 32(9):2004-2010.
    • (2007) Neuropsychopharmacology , vol.32 , Issue.9 , pp. 2004-2010
    • Zhang, L.1    Shirayama, Y.2    Iyo, M.3    Hashimoto, K.4
  • 75
    • 84898873540 scopus 로고    scopus 로고
    • Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of granulocyte-macrophage colony-stimulating factor in adult rats
    • Zhu F., Liu Y., Zhao J., Zheng Y. Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of granulocyte-macrophage colony-stimulating factor in adult rats. Neurobiologia 2014, 266:275-281.
    • (2014) Neurobiologia , vol.266 , pp. 275-281
    • Zhu, F.1    Liu, Y.2    Zhao, J.3    Zheng, Y.4
  • 76
    • 84899109433 scopus 로고    scopus 로고
    • Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats
    • Zhu F., Zheng Y., Ding Y.Q., Liu Y., Zhang X., Wu R., Guo X., Zhao J. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. PLoS One 2014, 9(4):e93966.
    • (2014) PLoS One , vol.9 , Issue.4
    • Zhu, F.1    Zheng, Y.2    Ding, Y.Q.3    Liu, Y.4    Zhang, X.5    Wu, R.6    Guo, X.7    Zhao, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.